Resolian Executive and Leadership Team

Robert Stachlewitz, the Chief Executive Officer at Resolian, directs the overarching corporate strategy and operational framework. Stachlewitz guides the integration of Alliance Pharma and Drug Development Solutions' expertise, ensuring a unified approach to therapeutic modality development. This leadership role involves fostering a culture of scientific excellence and driving the company's mission to provide world-class scientific solutions. Overseeing all major strategic initiatives, the Chief Executive Officer ensures alignment with market demands and long-term growth objectives. By championing innovation, Stachlewitz propels Resolian's impact in the global health sector. Robert Stachlewitz's vision shapes the company's direction, focusing on collaborative advancements across diverse therapeutic areas and solidifying Resolian's position as a leader in R&D services.

Alexander Abramov, the Chief Financial Officer at Resolian, manages all financial operations and fiscal strategy. Abramov oversees budgeting, forecasting, and financial reporting, ensuring robust fiscal health for the organization. This critical role involves optimizing financial resources to support the company's research and development initiatives and its fusion of expertise from Alliance Pharma and Drug Development Solutions. The Chief Financial Officer drives financial planning to facilitate strategic investments in new therapeutic modalities and operational scaling. By maintaining stringent financial controls, Abramov safeguards the company's assets and enhances shareholder value. Alexander Abramov's financial acumen is essential for navigating the complex economic landscape of the biopharmaceutical services industry and supporting Resolian's global market presence.

Jason Wang, the Site President at Resolian, directs operational activities and site-specific strategic execution. Wang oversees the day-to-day management of the Malvern facility, ensuring seamless integration of scientific processes and adherence to quality standards. This leadership position involves managing site resources, optimizing workflows, and fostering a productive environment for research and development teams. The Site President plays a crucial part in translating corporate objectives into tangible operational outcomes, supporting the company's mission to provide world-class scientific solutions. By focusing on site efficiency and innovation, Jason Wang contributes directly to Resolian's capacity to collaborate on all therapeutic modalities. Wang's leadership ensures the Malvern site functions as a hub of scientific excellence and operational reliability.

Laixin Wang, the Site President at Resolian, spearheads operational excellence and strategic site development. Wang manages the specific functions and resource allocation for their designated site, ensuring alignment with Resolian's broader goals of fusing expertise from Alliance Pharma and Drug Development Solutions. This executive role focuses on enhancing site capabilities to support diverse therapeutic modalities and drive scientific innovation. The Site President is responsible for implementing best practices in operational management and fostering a collaborative atmosphere among research personnel. By optimizing site performance, Laixin Wang directly contributes to the company's ability to deliver world-class scientific solutions. Wang's leadership ensures the effective execution of site-level strategies, reinforcing Resolian's commitment to advancing global health through cutting-edge R&D.